0FRI.LSE Lumibird S.A.
- Market cap
- EUR 346M
- P/E
- 124.9x
- P/B
- -
- ROE
- 9.8%
- Dividend yield
- 1.64%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.
Is 0FRI.LSE undervalued?
Graham numberThe Graham number of Lumibird S.A. cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Lumibird S.A. fundamental analysis
No fundamental analysis for Lumibird S.A. yet.
Lumibird S.A. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Lumibird S.A.
Lumibird SA designs, manufactures, and sells various lasers for scientific, industrial, and medical applications in France, Hong Kong, the United States, Germany, South Korea, China, and Austria. The company operates through Photonics and Medical divisions. It offers fiber lasers and amplifiers, high power fiber lasers, and solid-state lasers, laser diodes and components; and doppler wind LiDAR, time-of-flight LiDAR and rangefinders, military laser rangefinders, and medical …
Full company profileLumibird S.A. financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 1 quarter up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Lumibird S.A. annual financial statements
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 17.2M | 37.5M | 101M | 111M | 127M | 162M | 191M | 204M | 207M | 226M | 459M |
| Gross Profit | 2.86M | 3.74M | 12.2M | 12.7M | 13.2M | 18.5M | 15.4M | 17.3M | 13.1M | 24.6M | 80.0M |
| Operating Income | 2.63M | 3.38M | 11.4M | 12.3M | 14.1M | 19.8M | 16.4M | 18.5M | 15.0M | 25.7M | 34.4M |
| EBITDA | 3.55M | 4.92M | 16.7M | 19.5M | 18.0M | 31.9M | 32.1M | 27.3M | 31.0M | 45.4M | 48.0M |
| Net Income | 2.12M | 1.74M | 8.08M | 8.82M | 5.64M | 13.9M | 11.4M | 7.13M | 5.70M | 14.0M | 20.4M |
| EPS | 0.24 | 0.11 | 0.51 | 0.52 | 0.25 | 0.62 | 0.51 | 0.32 | 0.26 | 0.62 | 0.91 |
| Balance Sheet | |||||||||||
| Total Assets | 19.4M | 121M | 151M | 194M | 305M | 348M | 372M | 405M | 430M | 429M | 435M |
| Total Liabilities | 10.5M | 44.3M | 57.5M | 65.6M | 138M | 163M | 175M | 208M | 228M | 223M | 227M |
| Shareholders' Equity | 8.93M | 74.6M | 90.8M | 125M | 164M | 181M | 193M | 193M | 198M | 206M | 208M |
| Cash & Short-term Investments | 2.32M | 10.7M | 21.6M | 50.3M | 80.3M | 97.1M | 61.7M | 56.2M | 71.1M | 61.6M | 58.2M |
| Total Debt | 5.42M | 22.8M | 24.6M | 32.1M | 88.3M | 112M | 114M | 145M | 161M | 146M | 151M |
| Cash Flow | |||||||||||
| Operating Cash Flow | 4.05M | 7.17M | 11.6M | 19.5M | 13.1M | 26.6M | 1.43M | 20.7M | 34.4M | 23.1M | 8.00M |
| Capital Expenditure | 2.18M | 4.14M | 11.0M | 11.3M | 12.4M | 20.1M | 29.4M | 25.6M | 23.0M | 16.1M | 35.2M |
| Free Cash Flow | 1.87M | 3.03M | 540K | 8.19M | 747K | 6.47M | -28.0M | -4.89M | 11.4M | 7.00M | -27.2M |
| Ratios | |||||||||||
| ROE | 23.8% | 2.3% | 8.9% | 7.1% | 3.4% | 7.6% | 5.9% | 3.7% | 2.9% | 6.8% | 9.8% |
| ROA | 10.9% | 1.4% | 5.3% | 4.6% | 1.8% | 4.0% | 3.1% | 1.8% | 1.3% | 3.3% | 4.7% |
| Net Profit Margin | 12.4% | 4.6% | 8.0% | 8.0% | 4.4% | 8.5% | 5.9% | 3.5% | 2.7% | 6.2% | 4.4% |
| Debt to Equity | 0.61x | 0.31x | 0.27x | 0.26x | 0.54x | 0.62x | 0.59x | 0.75x | 0.81x | 0.71x | 0.73x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Lumibird S.A. dividends
- Dividend yield
- 1.64%
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | - | - | - |
| 2020 | - | - | - |
| 2019 | - | - | - |
| 2018 | - | - | - |
| 2017 | EUR 1.16M | 0.07 | 66.7% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 587:584 on Nov 27, 2018.
Who owns Lumibird S.A.
- Insiders 53.58%
- Institutions 17.68%
- Public & others 28.74%
- Shares outstanding 15.8M
- Free float 10.1M
Lumibird S.A. company profile
- Company name
- Lumibird S.A.
- Ticker
- 0FRI.LSE
- Exchange
- London Exchange
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Employees
- 1,078
- Fiscal year end
- December
- Address
- 2 rue Paul Sabatier, Lannion, France, 22300
- Phone
- 33 2 96 05 08 00
- Website
- lumibird.com
About Lumibird S.A.
Lumibird SA designs, manufactures, and sells various lasers for scientific, industrial, and medical applications in France, Hong Kong, the United States, Germany, South Korea, China, and Austria. The company operates through Photonics and Medical divisions. It offers fiber lasers and amplifiers, high power fiber lasers, and solid-state lasers, laser diodes and components; and doppler wind LiDAR, time-of-flight LiDAR and rangefinders, military laser rangefinders, and medical and ophthalmological solutions. The company serves defense and space, environment, topography and safety, industry and science, and science and healthcare industries. Lumibird SA was incorporated in 1970 and is headquartered in Lannion, France. Lumibird SA is a subsidiary of ESIRA.
Lumibird S.A. management
10- Dr. Marc Le FlohicCEO & Chairman · born 1963
- Mr. Andrew MoyseyGroup Chief Financial Officer
- Mr. Nicolas BallifDirector of Human Resources
- Mr. Philippe MetivierDirector of Research & Development · born 1961
- Mr. Frederic ChiquetChief Corporate Social Responsibility Officer
- Ms. Sonia RutnamChief Transformation Officer
- Mr. Nigel HolehouseProgram Director
- Mr. Jean-Marc GendreDeputy General Director & CEO of Lumibird Medical
- Ms. Aude Nomblot-GourhandFinancial Director
- Mr. Alexandre BillardDirector of the Photonics Division & Purchasing Director